Maralixibat Chloride T32873
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Lopixibat(Maralixibat, SHP-625) has the potential for the treatment of primary biliary cirrhosis, Alagille syndrome, and cholestatic liver disease.
CAS nr:
228113-66-4
Purity:
98%
Molecular Weight:
674,96
SMILES:
O=S1(CC(CCCC)(CCCC)[C@H](O)[C@H](C2=CC=C(OCC3=CC=C(C[N+]4(CC5)CCN5CC4)C=C3)C=C2)C6=CC(N(C)C)=CC=C61)=O
Formula:
C40H56N3O4S+
Pathway:
Target:
